tiprankstipranks
Trending News
More News >

Oragenics Announces Reverse Stock Split to Boost Share Price

Story Highlights
Oragenics Announces Reverse Stock Split to Boost Share Price

Don’t Miss TipRanks’ Half-Year Sale

Oragenics ( (OGEN) ) has shared an announcement.

On May 27, 2025, Oragenics, Inc. announced a One-for-Thirty reverse stock split of its common stock, effective June 3, 2025, to maintain its listing on the NYSE American. This move aims to increase the market price per share, aligning with investor expectations and strengthening the company’s capital markets presence. The reverse stock split will not affect the company’s authorized shares or the par value of its common and preferred stock, but will adjust the number of shares and exercise prices of outstanding options and warrants.

Spark’s Take on OGEN Stock

According to Spark, TipRanks’ AI Analyst, OGEN is a Underperform.

Oragenics exhibits significant financial distress, with ongoing unprofitability, negative equity, and cash flow issues, contributing to a low financial performance score. The technical indicators reflect a weak stock momentum, further exacerbating the negative outlook. Valuation metrics are unfavorable due to negative earnings and lack of dividends, highlighting the challenges facing the company. Overall, the stock’s fundamental and technical weaknesses are significant, resulting in a low overall score.

To see Spark’s full report on OGEN stock, click here.

More about Oragenics

Oragenics, Inc. is a clinical-stage biotechnology company focused on developing breakthrough treatments for neurological disorders. The company’s lead asset, ONP-002, is an innovative intranasal therapy designed to address the unmet medical need in concussion treatment. Oragenics is committed to pioneering new approaches in neuroscience to improve patient outcomes.

Average Trading Volume: 358,096

Technical Sentiment Signal: Strong Sell

Current Market Cap: $4.12M

Find detailed analytics on OGEN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1